Who invested in Infinant Health

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

HealthcareBiotech

Raised 5 months ago

Follow Infinant Health and see its new rounds in your feed.Start following

Funding summaryUpdated 31 Oct 2026

$39Mraised across 1 round since 2026, from 1 source

Latest round: Round, $39MJun 2026
Investors: 0

See who backed them

The rounds

Jun 2026
Round$39M
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yetSEC filing: $39M sold, first sale Jun 2026

Founders and team

From Infinant Health's own website: 16 on the team.

Mike JohnsonChief Executive Officer
Craig PensabeneVice President, Growth
Jennifer Van AkenSenior Vice President, Marketing
Arlene FosmerChief Science Officer
Christian BloomgrenChief Commercial Officer
Mandy KennedyChief Commercial Officer & Chief of Staff
Patrick CormierChief Financial Officer
Britta HeissVP - R&D
Amanda TrovatoQuality Systems and Controls Manager
Derek GordonDirector, Business Analytics & Operations
Fei MacLeodDirector, Brand Marketing
Iris StreimishDirector, Clinical Implementation
Lizabeth KurjiakaDirector, Strategic Product Lead
Melanie McNicholDirector, Commercial Marketing
Morgan StokesExecutive Director of Clinical Operations
Sabrina SamsonDirector, Marketing

Also claim to have backed them

These 3 firms list Infinant Health as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.